Marksans Pharma Ltd Share Price

Overview

Marksans Pharma Ltd share price is currently ₹312.69, down by - ₹4.89 (1.54%) from its previous closing price of ₹317.58. The share price has gained 20.62% over the past month and gained 72.55% over the past year. The stock's 52-week low and high are ₹152.22 and ₹339.27, respectively. Marksans Pharma Ltd has a market capitalisation of ₹ 14,560.00 Cr. The share price was last updated on 25 Aug 2026, 03:55 PM IST.

Marksans Pharma Ltd

MARKSANS

₹0.00

- ₹4.89

1.54%

Healthcare

₹0.00(%)1D

Updated: 25 Aug 2026, 03:55:24 pm IST

Market Data

Open Price

₹317.66

Prev. Close

₹317.58

₹309.28

Day Low

₹325.32

Day High

₹152.22

52 Week Low

₹339.27

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

27.43

Sector PE

42.03

PB Ratio

4.69

Sector PB

5.83

EPS

11.40

Dividend Yield

0.57

Today's Volume

1.673 M

5 Day Avg. Volume

2.140 M

PEG Ratio

2.80

Market Cap.

₹ 14,560.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 90% at ₹0.9/Share	20-Aug-2026	20-Aug-2026
DividendsFinal Dividend of 80% at ₹0.8/Share	01-Aug-2025	01-Aug-2025
DividendsFinal Dividend of 60% at ₹0.6/Share	17-Sep-2024	17-Sep-2024

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Bandhan Small Cap Fund - Regular Plan - Growth	35.55 Lac	37.82 Lac (6.37%)
UTI Small Cap Fund - Regular Plan - Growth	29.62 Lac	29.62 Lac no change
Kotak MNC Fund - Regular Plan - Growth	20.00 Lac	20.00 Lac no change
UTI Large & Mid Cap Fund - Regular Plan - Growth	20.60 Lac	19.73 Lac (4.21%)
Kotak Special Opportunities Fund - Regular Plan - Growth	25.48 Lac	17.60 Lac (30.91%)

Show all holdings

About Marksans Pharma Ltd 👋

Marksans Pharma Limited is engaged in research, manufacture, marketing and sales of pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two research and development centers; one located in Goa and the other in Navi Mumbai. Its focus areas lie in the over the counter (OTC) & prescription drugs that have ranging applications across fields like pain management, cough and cold, digestives, cardiovascular system (CVS), central nervous system (CNS) oncology, antidiabetic, and antibiotics. It has a diverse product portfolio of tablets (plain, enteric coated and film-coated), hard capsules, soft gelatin capsules, oral liquids and ointments. OTC product development for therapeutic categories such as pain management, upper respiratory, digestive health, vitamins, supplements, and anti-allergic treatments. Its prescription - Rx therapeutic segments include CVS, CNS, oncology, anti-diabetics and anti-biotic. It markets and distributes OTC products in Germany.